Literature DB >> 17360477

Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T.

Xiaodong Zhang1, Ailan Guo, Jianshi Yu, Anthony Possemato, Yueting Chen, Weiping Zheng, Roberto D Polakiewicz, Kenneth W Kinzler, Bert Vogelstein, Victor E Velculescu, Zhenghe John Wang.   

Abstract

Protein tyrosine phosphatase (PTP) receptor T (PTPRT) is the most frequently mutated PTP in human cancers. However, the cell signaling pathways regulated by PTPRT have not yet been elucidated. Here, we report identification of signal transducer and activator of transcription 3 (STAT3) as a substrate of PTPRT. Phosphorylation of a tyrosine at amino acid Y705 is essential for the function of STAT3, and PTPRT specifically dephosphorylated STAT3 at this position. Accordingly, overexpression of normal PTPRT in colorectal cancer cells reduced the expression of STAT3 target genes. These studies illuminate a mechanism regulating the STAT3 pathway and suggest that this signaling pathway plays an important role in colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360477      PMCID: PMC1802729          DOI: 10.1073/pnas.0611665104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Regulation of STAT3-mediated signaling by LMW-DSP2.

Authors:  Y Sekine; S Tsuji; O Ikeda; N Sato; N Aoki; K Aoyama; K Sugiyama; T Matsuda
Journal:  Oncogene       Date:  2006-04-24       Impact factor: 9.867

3.  Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells.

Authors:  Zhenghe Wang; Bert Vogelstein; Kenneth W Kinzler
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

Review 4.  The STATs of cancer--new molecular targets come of age.

Authors:  Hua Yu; Richard Jove
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

5.  Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein-tyrosine phosphatase domains of various RPTPs.

Authors:  C Blanchetot; J den Hertog
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

6.  Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases.

Authors:  A J Flint; T Tiganis; D Barford; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

7.  TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

Authors:  Christoph Becker; Massimo C Fantini; Christoph Schramm; Hans A Lehr; Stefan Wirtz; Alexei Nikolaev; Jürgen Burg; Susanne Strand; Ralf Kiesslich; Samuel Huber; Hiroaki Ito; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Peter R Galle; Manfred Blessing; Stefan Rose-John; Markus F Neurath
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

8.  Sequential Peptide Affinity (SPA) system for the identification of mammalian and bacterial protein complexes.

Authors:  Mahel Zeghouf; Joyce Li; Gareth Butland; Anna Borkowska; Veronica Canadien; Dawn Richards; Bryan Beattie; Andrew Emili; Jack F Greenblatt
Journal:  J Proteome Res       Date:  2004 May-Jun       Impact factor: 4.466

9.  The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation.

Authors:  Tetsuya Yamamoto; Yuichi Sekine; Keiichi Kashima; Atsuko Kubota; Noriko Sato; Naohito Aoki; Tadashi Matsuda
Journal:  Biochem Biophys Res Commun       Date:  2002-10-04       Impact factor: 3.575

10.  Mutational analysis of the tyrosine phosphatome in colorectal cancers.

Authors:  Zhenghe Wang; Dong Shen; D Williams Parsons; Alberto Bardelli; Jason Sager; Steve Szabo; Janine Ptak; Natalie Silliman; Brock A Peters; Michiel S van der Heijden; Giovanni Parmigiani; Hai Yan; Tian-Li Wang; Greg Riggins; Steven M Powell; James K V Willson; Sanford Markowitz; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Science       Date:  2004-05-21       Impact factor: 47.728

View more
  97 in total

Review 1.  Tumour suppressor function of protein tyrosine phosphatase receptor-T.

Authors:  Anthony Scott; Zhenghe Wang
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

Review 2.  Delving into somatic variation in sporadic melanoma.

Authors:  Vijay Walia; Euphemia W Mu; Jimmy C Lin; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

3.  Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation.

Authors:  Michael A Nalesnik; George Tseng; Ying Ding; Guo-Sheng Xiang; Zhong-liang Zheng; YanPing Yu; James W Marsh; George K Michalopoulos; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2012-02-08       Impact factor: 4.307

4.  Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation.

Authors:  Peng Zhang; Scott Becka; Sonya E L Craig; David T Lodowski; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Cell Commun Adhes       Date:  2009-12

5.  Epitope tagging of endogenous proteins for genome-wide ChIP-chip studies.

Authors:  Xiaodong Zhang; Chunguang Guo; Yueting Chen; Hennady P Shulha; Michael P Schnetz; Thomas LaFramboise; Cynthia F Bartels; Sanford Markowitz; Zhiping Weng; Peter C Scacheri; Zhenghe Wang
Journal:  Nat Methods       Date:  2008-01-06       Impact factor: 28.547

6.  Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes TH17 cell differentiation.

Authors:  Sevgi Keles; Louis Marie Charbonnier; Venkataraman Kabaleeswaran; Ismail Reisli; Ferah Genel; Nesrin Gulez; Waleed Al-Herz; Narayanaswamy Ramesh; Antonio Perez-Atayde; Neslihan E Karaca; Necil Kutukculer; Hao Wu; Raif S Geha; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2016-05-24       Impact factor: 10.793

Review 7.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer.

Authors:  Daniel E Johnson; Rachel A O'Keefe; Jennifer R Grandis
Journal:  Nat Rev Clin Oncol       Date:  2018-02-06       Impact factor: 66.675

8.  Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity.

Authors:  Nelson Ung; Tracy L Putoczki; Stanley S Stylli; Irvin Ng; John M Mariadason; Timothy A Chan; Hong-Jian Zhu; Rodney B Luwor
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

9.  DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway.

Authors:  Liana Adam; F Anthony San Lucas; Richard Fowler; Yao Yu; Wenhui Wu; Yulun Liu; Huamin Wang; David Menter; Michael T Tetzlaff; Joe Ensor; Ganiraju Manyam; Stefan T Arold; Chad Huff; Scott Kopetz; Paul Scheet; Michael J Overman
Journal:  Clin Cancer Res       Date:  2018-10-23       Impact factor: 12.531

10.  Identification of new SLE-associated genes with a two-step Bayesian study design.

Authors:  D L Armstrong; A Reiff; B L Myones; F P Quismorio; M Klein-Gitelman; D McCurdy; L Wagner-Weiner; E Silverman; J O Ojwang; K M Kaufman; J A Kelly; J T Merrill; J B Harley; S-C Bae; T J Vyse; G S Gilkeson; P M Gaffney; K L Moser; C Putterman; J C Edberg; E E Brown; J Ziegler; C D Langefeld; R Zidovetzki; C O Jacob
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.